These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11361464)

  • 21. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
    Infect Dis Obstet Gynecol; 2002; 10(1):3-64. PubMed ID: 12090361
    [No Abstract]   [Full Text] [Related]  

  • 22. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Ann Intern Med; 1997 Nov; 127(10):922-46. PubMed ID: 9382373
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USPHS and IDSA collaborate on guidelines to prevent opportunistic infections in HIV-infected persons.
    Kaplan JE; Holmes KK
    Emerg Infect Dis; 1995; 1(3):102-3. PubMed ID: 8903176
    [No Abstract]   [Full Text] [Related]  

  • 25. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    MMWR Recomm Rep; 1995 Jul; 44(RR-8):1-34. PubMed ID: 7565547
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of opportunistic infections in HIV infected patients. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Jul; 19(7):206-14. PubMed ID: 8766923
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latest opportunistic infection prevention guidelines.
    D'Amico R
    Posit Aware; 1998; 9(1):43-4. PubMed ID: 11365000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update: prophylaxis for HIV opportunistic infections.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(1):5-6. PubMed ID: 11365025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; Wilfert CM; Sperling R; Baker SA; Trapnell CB; Freedberg KA; Cotton D; Powderly WG
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S12-31. PubMed ID: 8547500
    [No Abstract]   [Full Text] [Related]  

  • 31. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Infectious Diseases Society of American.
    Ann Intern Med; 1999 Dec; 131(11):873-908. PubMed ID: 10610640
    [No Abstract]   [Full Text] [Related]  

  • 32. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    ; ;
    HIV Clin Trials; 2001; 2(6):493-554. PubMed ID: 11742438
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
    Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
    Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of AIDS and associated diseases].
    Rytik PG
    Klin Med (Mosk); 1997; 75(1):5-10. PubMed ID: 9082063
    [No Abstract]   [Full Text] [Related]  

  • 35. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part I. Prevention of Exposure.
    Am Fam Physician; 2000 Jan; 61(1):163-74. PubMed ID: 10643957
    [No Abstract]   [Full Text] [Related]  

  • 36. [HIV/AIDS treatment. Many attenuating drugs but still no remedy].
    Sandström E
    Vardfacket; 1993 Jun; 17(10):V-IX. PubMed ID: 8109133
    [No Abstract]   [Full Text] [Related]  

  • 37. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Ann Intern Med; 1996 Feb; 124(3):349-68. PubMed ID: 8554235
    [No Abstract]   [Full Text] [Related]  

  • 38. Opportunistic infections update.
    Proj Inf Perspect; 1999 Sep; (28):11-3. PubMed ID: 11367355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of HIV-associated opportunistic infections: 1997 recommendations.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1997 Dec; 22(12):69-73, 76, 79. PubMed ID: 9437673
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
    Popa LG; Popa MI; Zaharia A; Ocneanu M
    Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.